A landmark UK trial aiming to revolutionise prostate cancer screening has begun testing its first male participants. The ...

When we hear about mutations like the BRCA gene, it's usually associated with women and breast cancer screening. But researchers say not only do men get breast cancer, but the gene also shows risks ...

Researchers at the University of Cambridge have created the world's largest catalog of human breast cells, which has revealed early cell changes in healthy carriers of BRCA1 and BRCA2 gene mutations.

Scientists have developed a new clinical pathway for testing for the cancer-causing faults in the BRCA gene that could ensure patients get the right treatment and boost the number of people who get ...

Men with prostate cancer benefit from treatment with the pioneering drug olaparib – the first cancer drug to target inherited mutations – according to the results of a major trial presented today.

Mutations in the BRCA1 gene that are either inherited (germline) or acquired (somatic) might not be key to the initiation of prostate cancer, as previously thought, suggests the first study of its ...

Last year, EastEnders legend Kara Tointon underwent a double mastectomy and had her fallopian tubes removed after discovering ...

Clinical behavior of breast cancer in young BRCA carriers and prognostic impact of the timing of genetic testing: Results from an international cohort study. Menopausal hormone therapy and ovarian and ...

Prof Adam Rosenthal explores the potential for more personalised care for patients at risk of ovarian cancer not yet ready to ...

Prostate cancer screening plans could be scaled back even further, despite growing calls for more testing to be rolled out.